United Therapeutics (UTHR) Receives Paragraph IV from Sandoz for Generic Remodulin
Go back to United Therapeutics (UTHR) Receives Paragraph IV from Sandoz for Generic Remodulin| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 510.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $510.38 | 52 Week High | $164.04 | |||
| Open | $510.38 | 52 Week Low | $97.52 | |||
| Day High | $510.38 | P/E | 93.31 | |||
| Day Low | $510.38 | EPS | $5.47 | |||
| Volume | 573 | |||||
